The decline in Janux Therapeutics' share price is directly attributed to the market's reaction to their Q1 financial results. Typically, financial results can significantly impact a company's stock price, especially if they fall short of market expectations. The immediate negative reaction suggests that the results may have been below analyst predictions or the market's expectations, leading to a sell-off.